New CINV e-learning module

The Education and Training subcommittee are pleased to announce that our new e-learning module for Chemotherapy-induced Nausea and Vomiting (CINV) is now live on the BOPA website.

The module can be accessed under Supportive Care in the Courses & E-learning section of the BOPA website, or via the following direct link:

https://www.bopa.org.uk/lessons/chemotherapy-induced-nausea-and-vomiting-cinv/

We hope members find this e-learning valuable for their personal development.

This module was initiated and funded by Chugai Pharma UK Ltd and has been examined for compliance and accuracy.
Best wishes,
Diana Matthews

Education & Training Sub-Committee

Latest News

By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, cancer pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article
By BOPA Research Subcommittee on 14th July 2026

Record Abstract Submission for BOPA Annual Conference 2026

BOPA is thrilled to announce that we have received an incredible number of 235 abstracts for our annual conference 2026. The record number of abstract is testament to our continued…

Read article